The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
EUFOREA consensus on biologics for CRSwNP with or without asthma
Open accessAbstract
Novel therapies such as type 2 targeting biologics are emerging treatment options for patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely uncontrolled patients. The majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and over half of patients with asthma show a type 2 inflammatory signature in sinonasal mucosa and/or lungs. Importantly, both chronic respiratory diseases are frequent comorbidities, ensuring alleviation of both upper and lower airway pathology by systemic biological therapy. Type 2‐targeting biologics such as anti‐IgE, anti‐IL4Rα, anti‐IL5, and anti‐IL5Rα have entered the market for selected pheno/endotypes of asthma patients and may soon also become available for CRSwNP patients. Given the high prevalence of chronic respiratory diseases and the high cost associated with biologics, patient selection is crucial in order to implement such therapies into chronic respiratory disease care pathways. The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) organized a multidisciplinary Expert Board Meeting to discuss the positioning of biologics into the care pathways for CRSwNP patients with and without comorbid asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
Self-citationInternational ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Self-citationTwo Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Rabe, K. F., Nair, P., Brusselle, G., Maspero, J. F., Castro, M., Sher, L., Zhu, H., Hamilton, J. D., Swanson, B. N., Khan, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804093 · Cited by 1,184
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
Tomassen, P., Vandeplas, G., Van Zele, T., Cardell, L.-O., Arebro, J., Olze, H., Förster-Ruhrmann, U., Kowalski, M. L., Olszewska-Ziąber, A., Holtappels, G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1324 · Cited by 1,162
Self-citationChronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
Hastan, D., Fokkens, W. J., Bachert, C., Newson, R. B., Bislimovska, J., Bockelbrink, A., Bousquet, P. J., Brozek, G., Bruno, A., Dahlén, S. E., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02646.x · Cited by 1,112
Self-citationOlfactory Disorders and Quality of Life--An Updated Review
Croy, I., Nordin, S., & Hummel, T. (2014) · Chemical Senses · doi:10.1093/chemse/bjt072 · Cited by 917
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Self-citationGreen, R. H. (2002) · Thorax · doi:10.1136/thorax.57.10.875 · Cited by 848
Solèr, M., Matz, J., Townley, R., Buhl, R., O'Brien, J., Fox, H., Thirlwell, J., Gupta, N., & Della Cioppa, G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00092101 · Cited by 827
Bachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794 · cited 1×
“47,48,74 Each of these biologics is tested in phase III clinical trials for CRSwNP patients with results to FIGURE 1 Indications for biological treatment in patients with CRSwNP: proposal of the multidisciplinary EUFOREA Expert Board Meeting be expected in 2019.”
BackgroundSelf-citationOmalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Gevaert, P., Calus, L., Van Zele, T., Blomme, K., De Ruyck, N., Bauters, W., Hellings, P., Brusselle, G., De Bacquer, D., van Cauwenberge, P., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.047 · Cited by 744
Self-citationPosition paper on olfactory dysfunction
Hummel, T., Whitcroft, K. L., Andrews, P., Altundag, A., Cinghi, C., Costanzo, R. M., Damm, M., Frasnelli, J., Gudziol, H., Gupta, N., et al. (2017) · Rhinology journal · doi:10.4193/rhino16.248 · Cited by 713
Self-citationClinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Shaw, D. E., Sousa, A. R., Fowler, S. J., Fleming, L. J., Roberts, G., Corfield, J., Pandis, I., Bansal, A. T., Bel, E. H., Auffray, C., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00779-2015 · Cited by 555
[European position paper on rhinosinusitis and nasal polyps group].
Fokkens, W. J., Lund, V. J., & Mullol, J. (2008) · PubMed · Cited by 529
Self-citationReduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Bachert, C., Sousa, A. R., Lund, V. J., Scadding, G. K., Gevaert, P., Nasser, S., Durham, S. R., Cornet, M. E., Kariyawasam, H. H., Gilbert, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.044 · Cited by 505
Self-citationDeConde, A. S., Mace, J. C., Levy, J. M., Rudmik, L., Alt, J. A., & Smith, T. L. (2017) · The Laryngoscope · doi:10.1002/lary.26391 · Cited by 443
Shi, J. B., Fu, Q. L., Zhang, H., Cheng, L., Wang, Y. J., Zhu, D. D., Lv, W., Liu, S. X., Li, P. Z., Ou, C. Q., et al. (2015) · Allergy · doi:10.1111/all.12577 · Cited by 436
Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper
Kowalski, M. L., Agache, I., Bavbek, S., Bakirtas, A., Blanca, M., Bochenek, G., Bonini, M., Heffler, E., Klimek, L., Laidlaw, T. M., et al. (2019) · Allergy · doi:10.1111/all.13599 · Cited by 360
Self-citationCost of adult chronic rhinosinusitis: A systematic review
Smith, K. A., Orlandi, R. R., & Rudmik, L. R. (2015) · The Laryngoscope · doi:10.1002/lary.25180 · Cited by 354
Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
Bachert, C., Zhang, L., & Gevaert, P. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.010 · Cited by 317
Self-citationFarne, H. A., Wilson, A., Powell, C., Bax, L., & Milan, S. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010834.pub3 · Cited by 315
Hopkins, C., Slack, R., Lund, V., Brown, P., Copley, L., & Browne, J. (2009) · The Laryngoscope · doi:10.1002/lary.20653 · Cited by 297
Self-citationMechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S. (2017) · Allergy · doi:10.1111/all.13083 · Cited by 293
Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample
Hirsch, A. G., Stewart, W. F., Sundaresan, A. S., Young, A. J., Kennedy, T. L., Scott Greene, J., Feng, W., Tan, B. K., Schleimer, R. P., Kern, R. C., et al. (2017) · Allergy · doi:10.1111/all.13042 · Cited by 290
Dietz de Loos, D., Lourijsen, E. S., Wildeman, M. A. M., Freling, N. J. M., Wolvers, M. D. J., Reitsma, S., & Fokkens, W. J. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.986 · Cited by 268
Self-citationMultidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes
Liao, B., Liu, J. ‐., Li, Z. ‐., Zhen, Z., Cao, P. ‐., Yao, Y., Long, X. ‐., Wang, H., Wang, Y., Schleimer, R., et al. (2018) · Allergy · doi:10.1111/all.13411 · Cited by 241
Endotype-driven care pathways in patients with chronic rhinosinusitis
Bachert, C., Zhang, N., Hellings, P. W., & Bousquet, J. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.004 · Cited by 228
Self-citationErtaş, R., Özyurt, K., Atasoy, M., Hawro, T., & Maurer, M. (2017) · Allergy · doi:10.1111/all.13345 · Cited by 226
Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?
Hellings, P. W., Fokkens, W. J., Akdis, C., Bachert, C., Cingi, C., Dietz de Loos, D., Gevaert, P., Hox, V., Kalogjera, L., Lund, V., et al. (2013) · Allergy · doi:10.1111/all.12040 · Cited by 225
Self-citationAssociation between Severity of Asthma and Degree of Chronic Rhinosinusitis
Lin, D. C., Chandra, R. K., Tan, B. K., Zirkle, W., Conley, D. B., Grammer, L. C., Kern, R. C., Schleimer, R. P., & Peters, A. T. (2011) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2011.25.3613 · Cited by 216
Vlaminck, S., Vauterin, T., Hellings, P. W., Jorissen, M., Acke, F., Van Cauwenberge, P., Bachert, C., & Gevaert, P. (2014) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2014.28.4024 · Cited by 205
Self-citationToward clinically applicable biomarkers for asthma: An EAACI position paper
Diamant, Z., Vijverberg, S., Alving, K., Bakirtas, A., Bjermer, L., Custovic, A., Dahlen, S., Gaga, M., Gerth van Wijk, R., Del Giacco, S., et al. (2019) · Allergy · doi:10.1111/all.13806 · Cited by 201
Self-citationKhan, A., Vandeplas, G., Huynh, T. M. T., Joish, V. N., Mannent, L., Tomassen, P., Van Zele, T., Cardell, L. O., Arebro, J., Olze, H., et al. (2019) · Rhinology journal · doi:10.4193/rhin17.255 · Cited by 196
Self-citationEndotype-driven treatment in chronic upper airway diseases
De Greve, G., Hellings, P. W., Fokkens, W. J., Pugin, B., Steelant, B., & Seys, S. F. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0157-8 · Cited by 179
Self-citationHellings, P. W., Fokkens, W. J., Bachert, C., Akdiş, C. A., Bieber, T. R. M., Agache, I. O., Bernal‐Sprekelsen, M. S., Canonica, G. W., Gevaert, P., Joos, G., et al. (2017) · Allergy · doi:10.1111/all.13162 · Cited by 178
Self-citationvan der Veen, J., Seys, S. F., Timmermans, M., Levie, P., Jorissen, M., Fokkens, W. J., & Hellings, P. W. (2017) · Allergy · doi:10.1111/all.12983 · Cited by 172
Self-citationComorbid “treatable traits” in difficult asthma: Current evidence and clinical evaluation
Tay, T. R., & Hew, M. J. (2017) · Allergy · doi:10.1111/all.13370 · Cited by 162
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695_c · Cited by 160
Self-citationOn behalf of the CRES group, Philpott, C. M., Erskine, S., Hopkins, C. L., Kumar, N., Anari, S., Kara, N., Sunkaraneni, S., Ray, J., Clark, A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0823-y · Cited by 154
Self-citationNasal polyps in patients with asthma: prevalence, impact, and management challenges
Mullol, J., & Langdon, C. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s86251 · Cited by 140
Self-citationPrecision medicine in united airways disease: A “treatable traits” approach
Yii, A. C. A., Tay, T. R., Choo, X. N., Koh, M. S., Tee, A. K. H., & Wang, D. Y. (2018) · Allergy · doi:10.1111/all.13496 · Cited by 140
Voorham, J., Xu, X. P., Price, D. B., Golam, S. M., Davis, J. R., Ling, J. Z. J., Kerkhof, M., Ow, M., & Tran, T. N. (2018) · Allergy · doi:10.1111/all.13556 · Cited by 121
Tomassen, P., Newson, R. B., Hoffmans, R., Lötvall, J. O., Cardell, L., Gunnbjörnsdóttir, M., Thilsing, T., Matricardi, P. M., Krämer, U., Makowska, J. S., et al. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02503.x · Cited by 119
Self-citationHopkins, C. L., Rimmer, J., & Lund, V. J. (2015) · Rhinology Journal · doi:10.4193/rhino13.217 · Cited by 113
Self-citationTotal IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
Weller, K., Ohanyan, T., Hawro, T., Ellrich, A., Sussman, G., Koplowitz, J., Giménez‐Arnau, A. M., Peveling‐Oberhag, A., Staubach, P., Metz, M., et al. (2018) · Allergy · doi:10.1111/all.13586 · Cited by 110
Pundir, V., Pundir, J., Lancaster, G., Baer, S., Kirkland, P., Cornet, M., Lourijsen, E. S., Georgalas, C., & Fokkens, W. J. (2016) · Rhinology Journal · doi:10.4193/rhin15.079 · Cited by 108
Self-citationOmalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study
Bidder, T., Sahota, J., Rennie, C. E., Lund, V. J., Robinson, D. S., & Kariyawasam, H. H. (2017) · Rhinology Journal · doi:10.4193/rhin17.139 · Cited by 96
Self-citationRudmik, L. R., Soler, Z. M., Hopkins, C. L., Schlosser, R. J., Peters, A. T., White, A. A., Orlandi, R. R., Fokkens, W. J., Douglas, R. G., & Smith, T. L. (2016) · Rhinology Journal · doi:10.4193/rhin16.023 · Cited by 91
Self-citationCluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients
Seys, S., Scheers, H., den Brande, P. V., Marijsse, G., Dilissen, E., Bergh, A. V. D., Goeminne, P., Hellings, P. W., Ceuppens, J. L., Dupont, L., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0524-y · Cited by 87
Self-citationBiologic Therapy and Novel Molecular Targets of Severe Asthma
Pepper, A. N., Renz, H. E., Casale, T. B., & Garn, H. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.04.038 · Cited by 87
Immunological and hematological effects of IL ‐5(Rα)‐targeted therapy: An overview
Hassani, M., & Koenderman, L. (2018) · Allergy · doi:10.1111/all.13451 · Cited by 87
Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis
Schlosser, R. J., Smith, T. L., Mace, J., & Soler, Z. M. (2016) · Allergy · doi:10.1111/all.13048 · Cited by 78
Hopkins, C., Rimmer, J., & Lund, V. J. (2015) · Rhinology Journal · doi:10.4193/rhin13.217 · Cited by 77
Self-citationZhang, Y., Derycke, L., Holtappels, G., Wang, X. D., Zhang, L., Bachert, C., & Zhang, N. (2018) · Allergy · doi:10.1111/all.13489 · Cited by 76
Self-citationStaubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Maurer, M., & Weller, K. (2018) · Allergy · doi:10.1111/all.13339 · Cited by 65
Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study
Ostovar, A., Fokkens, W. J., Vahdat, K., Raeisi, A., Mallahzadeh, A., & Farrokhi, S. (2019) · Rhinology Journal · doi:10.4193/rhin18.061 · Cited by 64
Self-citationHellings, P. W., Akdiş, C. A., Bachert, C., Bousquet, J. J., Pugin, B., Adriaensen, G. F. J. P. M., Advani, R., Agache, I. O., Anjo, C., Anmolsingh, R., et al. (2017) · Rhinology Journal · doi:10.4193/rhin17.028 · Cited by 61
Self-citationClinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History
Wu, D., Bleier, B. S., Li, L., Zhan, X., Zhang, L., Lv, Q., Wang, J., & Wei, Y. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.09.020 · Cited by 60
Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids
Phillips, K. M., Hoehle, L. P., Bergmark, R. W., Campbell, A. P., Caradonna, D. S., Gray, S. T., & Sedaghat, A. R. (2017) · Rhinology Journal · doi:10.4193/rhin17.029 · Cited by 50
Sahlstrand-Johnson, P., Hopkins, C. L., Ohlsson, B., & Ahlner‐Elmqvist, M. (2017) · Rhinology Journal · doi:10.4193/rhin16.126 · Cited by 46
Self-citationPhillips, K. M., Bergmark, R. W., Hoehle, L. P., Caradonna, D. S., Gray, S. T., & Sedaghat, A. R. (2018) · Rhinology Journal · doi:10.4193/rhin18.033 · Cited by 33
Prevention of chronic rhinosinusitis
Hopkins, C. L., Šurda, P., Bast, F., Hettige, R., Walker, A., & Hellings, P. W. (2018) · Rhinology Journal · doi:10.4193/rhin17.027 · Cited by 32
Self-citationKilty, S., Lasso, A., Endam, L. M., & Desrosiers, M. Y. (2018) · Rhinology Journal · doi:10.4193/rhin17.115 · Cited by 29
Self-citationThe risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review
Winblad, L., Larsen, C. G., Håkansson, K., Abrahamsen, B., & von Buchwald, C. (2017) · Rhinology Journal · doi:10.4193/rhin15.367 · Cited by 21
Prevention of Chronic Rhinosinusitis
Hopkins, C. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813471-9.00018-9 · Cited by 18
Self-citation
Cited by
EPOS2020: A Major Step Forward
Fokkens, W. J. (2020) · Rhinology journal · doi:10.4193/rhin20.401 · Cited by 1,240
Self-citationExecutive Summary of EPOS 2020 Including Integrated Care Pathways
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., & Mullol, J. (2020) · Rhinology journal · doi:10.4193/rhin20.601 · Cited by 533
Self-citationPathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Type 2 immunity in allergic diseases
Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Ardicli, S., Li, M., D’Avino, P., Beha, C., Babayev, H., Zhao, B., et al. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01261-2 · Cited by 362
Bachert, C., Han, J. K., Wagenmann, M., Hosemann, W., Lee, S. E., Backer, V., Mullol, J., Gevaert, P., Klimek, L., Prokopakis, E., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.013 · Cited by 355
Self-citation
Metadata
- Authors
- Fokkens, W. J., Lund, V., Bachert, C., Mullol, J., Bjermer, L., Bousquet, J., Canonica, G. W., Deneyer, L., Desrosiers, M., Diamant, Z., Han, J., Heffler, E., Hopkins, C., Jankowski, R., Joos, G., Knill, A., Lee, J., Lee, S. E., Mariën, G., Pugin, B., Senior, B., Seys, S. F., & Hellings, P. W.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2019-07-15
- Volume
- 74
- Issue
- 12
- Pages
- 2312-2319
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2946585587
- Cited by
- 390
- References
- 69
- FWCI
- 30.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.